ಬೆಂಗಳೂರು: ಸೆನ್ಸೆಕ್ಸ್ ಮತ್ತು ನಿಫ್ಟಿ ಹೂಡಿಕೆದಾರರಿಂದ ಭಾರಿ ಮಾರಾಟವನ್ನು ಕಂಡಿದ್ದರಿಂದ ಹಣಕಾಸು ವರ್ಷ 2021 ರ ಮೊದಲ ದಿನ ಕೆಂಪು ಬಣ್ಣದಲ್ಲಿತ್ತು. ಎರಡೂ ಮಾರುಕಟ್ಟೆಗಳು ಇಂದು ಕೆಳಮಟ್ಟದಲ್ಲಿ ತೆರೆದವು ಮತ್ತು ಮುಕ್ತಾಯದ ಘಂಟೆಯೊಂದಿಗೆ ಶೇಕಡ 4 ರಷ್ಟು ಮತ್ತಷ್ಟು ಕುಸಿದವು ಎಂದು ಏಂಜಲ್ ಬ್ರೋಕಿಂಗ್ ಲಿಮಿಟೆಡ್ ಸಂಸ್ಥೆಯ ಹೆಡ್ ಅಡ್ವೆಂಸರಿ ಆಮರ್ ದಿಯೋ ಸಿಂಗ್ ಹೇಳಿದರು.
ಐಟಿ ಮತ್ತು ಬ್ಯಾಂಕಿಂಗ್ ಷೇರುಗಳು ಮಾರುಕಟ್ಟೆಯ ಕೆಳಕ್ಕೆ ಇಳಿಯಲು ಹೆಚ್ಚಿನ ಕೊಡುಗೆ ನೀಡಿವೆ. ಟೆಕ್ ಮಹೀಂದ್ರಾ, ಟಿಸಿಎಸ್, ಮತ್ತು ಮೈಂಡ್ಟ್ರೀ ಸೇರಿದಂತೆ ಉನ್ನತ ಐಟಿ ಆಟಗಾರರು ಇಂದು 9.5% ರಷ್ಟು ಕುಸಿದಿದ್ದಾರೆ. ಕೊಟಕ್ ಬ್ಯಾಂಕ್ (ಎನ್ಎಸ್ಇ) ಕೂಡ ಶೇಕಡ 8.83 ರಷ್ಟು ಕುಸಿದಿದೆ.
ಎಲ್ಲಾ ಮಾರುಕಟ್ಟೆ ಪ್ರಸ್ತುತ ಪ್ರವೃತ್ತಿಗಳನ್ನು ಕೊರೊನಾ ವೈರಸ್ ಏಕಾಏಕಿ ನಡೆಸುತ್ತಿದೆ. ಭಾರತದಲ್ಲಿ ಕೋವಿಡ್-19 ಪ್ರಕರಣಗಳ ಸಂಖ್ಯೆಯಲ್ಲಿ ಏರಿಕೆ ಕಂಡುಬಂದಿದೆ. ಧಾರ್ಮಿಕ ಮೆರವಣಿಗೆಗಳು ಮತ್ತು ಸಾಮೂಹಿಕ ವಲಸೆಯಂತಹ ಘಟನೆಗಳು ಮುಂಬರುವ ಕೆಲವು ದಿನಗಳಲ್ಲಿ ಕೋವಿಡ್ ಪ್ರಕರಣಗಳು ಮತ್ತಷ್ಟು ಹೆಚ್ಚಾಗಬಹುದು ಎನ್ನುವ ಭೀತಿ ಮತ್ತಷ್ಟು ಹುಟ್ಟುಹಾಕಿದೆ. ಇದರ ನೇರ ಪರಿಣಾಮವನ್ನು ಷೇರು ಮಾರುಕಟ್ಟೆಯೊಳಗಿನ ಹೂಡಿಕೆದಾರರ ಮನೋಭಾವದ ಮೇಲೆ ಕಾಣಬಹುದು.
ಕೊರೊನಾ ವೈರಸ್ ಲಾಕ್ ಡೌನ್ ಬಳಿಕ ವಾಹನ ಮಾರಾಟದಲ್ಲಿ ತೀವ್ರ ಕುಸಿತ ಕಂಡುಬಂದಿದೆ. ಭಾರತದ ಅತಿದೊಡ್ಡ ಆಟೋಮೊಬೈಲ್ ಸಂಸ್ಥೆ ಮಾರುತಿ ಸುಜುಕಿ ಫೆಬ್ರವರಿಯಲ್ಲಿ 158,076 ಯುನಿಟ್ಗಳಿಂದ ಮಾರ್ಚ್ ತಿಂಗಳಲ್ಲಿ 83,792 ಯುನಿಟ್ಗಳಿಗೆ ಇಳಿದಿದೆ. ಅಶೋಕ್ ಲೇಲ್ಯಾಂಡ್ ಮಾರ್ಚ್ ನಲ್ಲಿ ಶೇಕಡ 90 ಕ್ಕಿಂತಲೂ ಕಡಿಮೆಯಾಗಿದೆ. ಪರಿಣಾಮ ಆಟೋ ಸೂಚ್ಯಂಕ ಕೆಂಪು ಬಣ್ಣದಲ್ಲಿತ್ತು, ನಿಫ್ಟಿ ಆಟೋ ಸೂಚ್ಯಂಕ ಶೇಕಡ 1.56 ಮತ್ತು ಬಿಎಸ್ಇ ಆಟೋ ಸೂಚ್ಯಂಕ ಶೇಕಡ 1.54 ರಷ್ಟು ಕುಸಿಯಿತು. ಹೀರೋ ಮೊಟೊಕಾರ್ಪ್, ಬಜಾಜ್ ಆಟೋ, ಮತ್ತು ಎಕ್ಸೈಡ್ ಇಂಡಸ್ಟ್ರೀಸ್ ಸೇರಿದಂತೆ ಕೆಲವೇ ಕೆಲವು ಆಟೋ ಸ್ಟಾಕ್ಗಳು ಇಂದು ವಿರುದ್ಧ ದಿಕ್ಕಿನಲ್ಲಿ ನಡೆದಿವೆ.
ಮಾರ್ಚ್ ನಲ್ಲಿ ಎಫ್ಪಿಐಗಳು ಭಾರತೀಯ ಇಕ್ವಿಟಿ ಮಾರುಕಟ್ಟೆಯಿಂದ 9 15.9 ಬಿಲಿಯನ್ ದಾಖಲೆಯನ್ನು ಹೊರಹಾಕಿದವು. ಈ ಎಫ್ಪಿಐ ಹೊರಹರಿವು ಏಷ್ಯಾದಲ್ಲಿ ಅತಿ ಹೆಚ್ಚು ಮತ್ತು ಮಾರುಕಟ್ಟೆಯನ್ನು ಕೆಳಕ್ಕೆ ಎಳೆದಿದೆ. ಮುಂಬರುವ ಕೆಲವು ದಿನಗಳಲ್ಲಿ ಭಾರತದಲ್ಲಿನ ನಿಯಂತ್ರಣ ಕ್ರಮಗಳಿಗೆ ಎಫ್ಪಿಐಗಳು ಹೇಗೆ ಪ್ರತಿಕ್ರಿಯಿಸುತ್ತವೆ ಎಂಬುದನ್ನು ನೋಡಲು ಇದು ನಿರ್ಣಾಯಕವಾಗಿರುತ್ತದೆ.
ಪ್ರಮುಖ ಸೂಚ್ಯಂಕಗಳು ಶೇಕಡ 5 ನಷ್ಟು ಕುಸಿದಿದ್ದರಿಂದ ಇಂದು ಇಡೀ ಏಷ್ಯಾದ ಮಾರುಕಟ್ಟೆಗೆ ಇದು ಕೆಟ್ಟ ದಿನವಾಗಿತ್ತು. ಪ್ಯಾನ್-ಯುರೋಪಿಯನ್ ಎಸ್ಟಿಒಎಕ್ಸ್ಎಕ್ಸ್ 600 ರೊಂದಿಗೆ ಯುರೋಪಿಯನ್ ಮಾರುಕಟ್ಟೆಗಳಲ್ಲಿ ಒತ್ತಡವು ಶೇಕಡ 3.2 ರಷ್ಟು ಕುಸಿದಿದೆ. ಯುಎಸ್ ಸಾವಿನ ಕಠೋರ ದೃಷ್ಟಿಕೋನದಿಂದಾಗಿ ವಾಲ್ ಸ್ಟ್ರೀಟ್ ಫ್ಯೂಚರ್ಸ್ ಸಹ ಶೇಕಡ 3.1 ಕಡಿಮೆ ವಹಿವಾಟು ನಡೆಸಿತು.
The lockdown is absolutely essential, but essential services should not suffer. Isolation is the best thing we can do now. Let us look at it step-wise. First, we have to work on prevention. What are the maximum precautions a person can take? Other than isolation people talk of sanitisation. I accept that. If you are sanitising your hands why aren’t you sanitizing inside your nose and mouth and inside your lungs? In my personal opinion steam inhalation twice a day is advisable, it doesn’t cost anything, in addition to that gargling once a day with Listerine is also good since alcohol kills viruses.
Dear, Brother’s, Sisters’s, Friends & Relatives, Kindly Stay at Home to Save Your Precious life, Suffer Now & Enjoy Later. Staying at Home is the One and Only Option.
I Request One & all With Folded Hand To Stay at Home.
· Koki Sato to lead Takeda’s business in India, ensuring patient access to highly innovative medicines
· Seasoned biopharmaceutical leader with over 17 years of experience across geographies
01 April, 2020: Takeda India announced today the appointment of Koki Sato as the Country Head for the Company’s India business. In his current capacity, he will lead the company’s operations with a focus on the expansion of patient access to Takeda’s highly innovative portfolio in the country.
Koki joined Takeda in 2003 and, since then, grew within the company to hold various senior international roles across multiple functions, including Commercial Operations, Finance, and HR. Prior to this role, Koki was the General Manager of Ukraine, Belarus, and Moldova (UBM) Cluster in Takeda’s ICMEA* Area.
Commenting on his new role, Koki Sato said, “India is of significant importance for Takeda and we endeavor to develop initiatives which will lead to enhanced patient access to our highly innovative medicines locally. We remain committed to serving India’s patients, and aim to bring newer therapies for rare diseases, gastroenterology, and oncology to them in the coming years, along with hopefully, our Dengue vaccine candidate.”
Across its ICMEA* Area, and more broadly across the countries that span its Growth & Emerging Markets Business Unit, Takeda collaborates with healthcare providers, governments and regulators, to ensure that its portfolio of innovative medicines is made available to patients as quickly and safely as possible.
Koki will be officially assuming his position from April 1, 2020. He is a Japanese national and holds a Bachelor of Arts degree in Political Science and Economics from Waseda University, Japan.
* ICMEA:India, the Commonwealth of Independent States, the Middle East (including Turkey), & Africa
– ENDS –
About Takeda India
Takeda India is part of Takeda Pharmaceutical Company Limited’s group of companies, headquartered in Japan. In the country, the company currently focuses on the therapeutic areas of Rare Diseases, including Hemophilia and Lysosomal Storage Disorders and plasma-derived therapies. Takeda has a presence across the Indian subcontinent, including in Sri Lanka, Nepal, and Bangladesh.
About Takeda Pharmaceuticals
Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Gastroenterology (G.I.), Neuroscience, and Rare Diseases. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions. For more information, visit https://www.takeda.com
Takeda’s Forward-Looking Statements This press release contains “forward-looking statements.” Forward-looking statements include all statements other than statements of historical fact, including plans, strategies and expectations for the future, statements regarding the expected timing of filings and approvals relating to the transaction, the expected timing of the completion of the transaction, the ability to complete the transaction or to satisfy the various closing conditions, future revenues and profitability from or growth or any assumptions underlying any of the foregoing. Statements made in the future tense, and words such as “anticipate,” “expect,” “project,” “continue,” “believe,” “plan,” “estimate,” “pro forma,” “intend,” “potential,” “target,” “forecast,” “guidance,” “outlook,” “seek,” “assume,” “will,” “may,” “should,” and similar expressions are intended to qualify as forward-looking statements. Forward-looking statements are based on estimates and assumptions made by management that are believed to be reasonable, though they are inherently uncertain and difficult to predict. Investors and security holders are cautioned not to place undue reliance on these forward-looking statements.
Forward-looking statements involve risks and uncertainties that could cause actual results or experience to differ materially from that expressed or implied by the forward-looking statements. Some of these risks and uncertainties include, but are not limited to: required regulatory approvals for the transaction may not be obtained in a timely manner, if at all; the conditions to closing of the transaction may not be satisfied; competitive pressures and developments; applicable laws and regulations; the success or failure of product development programs; actions of regulatory authorities and the timing thereof; changes in exchange rates; and claims or concerns regarding the safety or efficacy of marketed products or product candidates in development. The forward-looking statements contained in this press release speak only as of the date of this press release, and neither Portal Instruments nor Takeda undertake any obligation to revise or update any forward-looking statements to reflect new information, future events or circumstances after the date of the forward-looking statement. If one or more of these statements is updated or corrected, investors and others should not conclude that additional updates or corrections will be made.
5 Final Year Fashion Students of LISAA School of Design, a premier fashion school have designed Red Carpet dress worn by Canadian Pop Singer , Celine Dion .
The name of the design students are Parnika, Vidushi, Athira, Smriti and Kritika . These students were given a certificate of appreciation by the institute and the cost of the fabric was covered by the institute itself.
“Being teamed up with classmates made it both fun and efficient. We were able to strategically use each one’s refined skill and accomplish the task.” says Parnika.
“The brains of some, the patience, sensibility and neatness of the others had enabled the division of work to be very simple. Everyone knew their part and there was no need to worry about the outcome,” adds Vidushi, Final Year Student.
Athira further adds, “Moreover, all of us adored the design and hence put wholesome effort to ensure that our version of it would be just as elegant and charming as the original.”
“Right from figuring the construction and patterns multiple times, to choosing the fabric, to dealing with the length and bulk of the garment, which although seemed simple, had been quite challenging,” recounts Smriti, Final Year Student.
“This task also enabled us to learn the intricacies of haute couture, which is essential with our upcoming individual couture collections. We managed to do our job, whilst having an overwhelming experience, making it an endeavor we shall all always remember,” says Kritika , Final Year Student .
The teachers of the Pattern Making Department who helped out the students in re-creating the dress said, ‘Through our years of experience ,each time re-creation project brings in new surprise and challenges to out do the past work. Huge volume requires meterage from 30 to 250 meters , manipulating such scale is not only cumbersome but to validate a new beginning.’
Avi Keswani, Founder & Director, LISAA School of Design says, “It was an assignment part of the curriculum known as the Re-creation project to understand the importance of Haute Couture and how to replicate phenomenal couture designs of iconic designers. It took our students about 1.5 months to complete this entire garment as a group project .The materials used were satin and the technique of boning was used for corset. ”
ಬೆಂಗಳೂರು: ಸಾಂಕೇತಿಕ ಪ್ರದರ್ಶನದಲ್ಲಿ ಸ್ಟಾಕ್ ಮಾರುಕಟ್ಟೆಗಳು ಎಫ್ವೈ 2020 ಅನ್ನು ಸುಮಾರು 4% ರಷ್ಟು ಬಲವಾದ ಬುಲ್ ರನ್ನೊಂದಿಗೆ ಮುಚ್ಚಿದೆ. ಎಸ್ & ಪಿ ಸೆನ್ಸೆಕ್ಸ್ ಶೇಕಡ 3.62 ಲಾಭದೊಂದಿಗೆ 1,000 ಪಾಯಿಂಟ್ಗಳ ಉತ್ತರಕ್ಕೆ ಏರಿದರೆ, 326 ಪಾಯಿಂಟ್ಗಳ ರ್ಯಾಲಿಯ ನಿಫ್ಟಿ 3.82% ಏರಿಕೆ ಕಂಡಿದೆ ಎಂದು ಏಂಜಲ್ ಬ್ರೋಕಿಂಗ್ ಲಿಮಿಟೆಡ್ ಸಂಸ್ಥೆಯ ಹೆಡ್ ಅಡ್ವೆಂಸರಿ ಆಮರ್ ದಿಯೋ ಸಿಂಗ್ ಹೇಳಿದರು.
ಕ್ವಾಟರ್ 4 ನ 2020 ರಲ್ಲಿ ಎರಡೂ ಮಾರುಕಟ್ಟೆಗಳ ಇತಿಹಾಸದಲ್ಲಿ ಅತ್ಯಂತ ಕೆಟ್ಟ ತ್ರೈಮಾಸಿಕಗಳಲ್ಲಿ ಒಂದಾಗಿದೆ. 1992 ರಿಂದ ನಿಫ್ಟಿ ತನ್ನ ಅತ್ಯಂತ ಭಯಾನಕ ತ್ರೈಮಾಸಿಕವನ್ನು ಕಂಡರೆ, 2020 ರ ಕೊನೆಯ ಹಂತವು ಸೆನ್ಸೆಕ್ಸ್ ಇತಿಹಾಸದಲ್ಲಿ ಅತ್ಯಂತ ಕೆಟ್ಟದಾಗಿದೆ.
ಫೆಬ್ರವರಿಯಲ್ಲಿ ದಾಖಲೆಯ ಕನಿಷ್ಠ 35.7 ರಿಂದ ಮರುಕಳಿಸುವ ಮೂಲಕ ಚೀನಾದ ಉತ್ಪಾದನಾ ಚಟುವಟಿಕೆಯು ಮಾರ್ಚ್ನಲ್ಲಿ 52 ಪಾಯಿಂಟ್ಗಳ ಪಿಎಂಐನೊಂದಿಗೆ ಸಂಕೋಚನದ ಪ್ರವೃತ್ತಿಯನ್ನು ಹೆಚ್ಚಿಸಿದೆ. ಸ್ಮಾಲ್ ಕ್ಯಾಪ್, ಮಿಡ್ ಕ್ಯಾಪ್ ಮತ್ತು ದೊಡ್ಡ ಕ್ಯಾಪ್ ವಿಭಾಗಗಳಲ್ಲಿ ರ್ಯಾಲಿಗಳನ್ನು ಹೊಂದಿರುವ ಎಲ್ಲಾ ದೊಡ್ಡ ಮತ್ತು ಸಣ್ಣ ಸೂಚ್ಯಂಕಗಳಲ್ಲಿ ಸಕಾರಾತ್ಮಕ ಭಾವನೆ ಇಂದು ಕಂಡುಬಂತು. ದಿನದ ವ್ಯಾಪಾರವು ಮಾರುಕಟ್ಟೆಗೆ ‘ಪವರ್’ ಆಟವಾಗಿ ಹೊರಹೊಮ್ಮಿತು, ಪವರ್ ಸ್ಟಾಕ್ಗಳು ಕೆಲವು ಉತ್ತಮ ಪ್ರದರ್ಶನ ನೀಡುವವರಾಗಿವೆ.
ಮಾರ್ಚ್ ತಿಂಗಳಲ್ಲಿ ಭಾರತೀಯ ಷೇರು ಮಾರುಕಟ್ಟೆಗಳಿಂದ ವಿದೇಶಿ ಬಂಡವಾಳ ಹೂಡಿಕೆದಾರರ (ಎಫ್ಪಿಐ) ಹೆಚ್ಚಿನ ಹೊರಹರಿವು ಕಂಡುಬಂದಿದೆ. ಒಟ್ಟಾರೆಯಾಗಿ ಎಫ್ಪಿಐ ಹೊರಹರಿವು ರೂ. 58,348 ಕೋಟಿ ರೂ., ಇದು ನ್ಯಾಷನಲ್ ಸೆಕ್ಯುರಿಟೀಸ್ ಡಿಪಾಸಿಟರಿ ಲಿಮಿಟೆಡ್ (ಎನ್ಡಿಎಸ್ಎಲ್) ನಲ್ಲಿ ಲಭ್ಯವಿರುವ ಮಾಹಿತಿಯ ಪ್ರಕಾರ ಅತಿ ಹೆಚ್ಚು.
City Today News 
You must be logged in to post a comment.